This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: January 21, 2025
Source: https://www.investing.com/news/sec-filings/seelos-therapeutics-files-for-chapter-11-bankruptcy-93CH-3737578
Reason: Filed for bankruptcy
Last recorded trade on: January 21, 2025
Source: https://www.investing.com/news/sec-filings/seelos-therapeutics-files-for-chapter-11-bankruptcy-93CH-3737578
Seelos Therapeutics
SEEL
₹31.74
Share price
-31.49%
Change (1 day)
-98.05%
Change (1 year)
Categories
Seelos Therapeutics (SEEL) - Total liabilities
Total liabilities on the balance sheet as of June 2024 : ₹2.61 Billion
According to Seelos Therapeutics 's latest financial reports the company's total liabilities are ₹2.61 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Seelos Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | ₹3.24 B | 17.4% |
| 2022-12-31 | ₹2.76 B | 41.67% |
| 2021-12-31 | ₹1.94 B | 78.54% |
| 2020-12-31 | ₹1.09 B | 37.83% |
| 2019-12-31 | ₹0.79 B | 853.15% |
| 2018-12-31 | ₹83.06 M | -44.28% |
| 2017-12-31 | ₹0.14 B | -82.04% |
| 2016-12-31 | ₹0.83 B | -29.52% |
| 2015-12-31 | ₹1.17 B | 44.19% |
| 2014-12-31 | ₹0.81 B | 7.18% |
| 2013-12-31 | ₹0.76 B | -19.33% |
| 2012-12-31 | ₹0.94 B | 51.4% |
| 2011-12-31 | ₹0.62 B | 90.88% |
| 2010-12-31 | ₹0.32 B | -61.34% |
| 2009-12-31 | ₹0.84 B | 150.47% |
| 2008-12-31 | ₹0.33 B | 46.63% |
| 2007-12-31 | ₹0.23 B | -38.31% |
| 2006-12-31 | ₹0.37 B | -34.63% |
| 2005-12-31 | ₹0.57 B | 48.65% |
| 2004-12-31 | ₹0.38 B | -18.94% |
| 2003-12-31 | ₹0.47 B | -9.46% |
| 2002-12-31 | ₹0.52 B | 238.32% |
| 2001-12-31 | ₹0.15 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | ₹1.98 B | -24.23% | 🇺🇸 USA |